The Net Margin of BrightPath Biotherapeutics Co Ltd (4594.T) is -1622336.10%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | -1622336.10% |
| 2023-03-31 | -28136.99% |
| 2022-03-31 | -9632.61% |
| 2021-03-31 | -68675.48% |
| 2020-03-31 | -16440.48% |
| 2019-03-31 | -1209.38% |
| 2018-03-31 | -445.00% |
| 2017-03-31 | -210.28% |
| 2016-03-31 | -120.90% |
| 2015-03-31 | -50.20% |